Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35,740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
Zhang Y, Zhang P, Tian X, Chen G, Li Y, Zhang Y, Xu Z, Wei Z, Zhang W, Ma L, Shi B, Liao L, Wang J. Zhang Y, et al. Among authors: xu z. World J Urol. 2019 Nov;37(11):2481-2492. doi: 10.1007/s00345-019-02698-7. Epub 2019 Feb 26. World J Urol. 2019. PMID: 30809700 Clinical Trial.
The characteristics and risk factors of healthcare-seeking men with lower urinary tract symptoms in China: Initial report from the POInT group.
Song QX, He F, Sun X, Liu K, Chen Z, Li M, Lin J, Xu Z, Li Y, Zhang Y, Huang H, Zhang Y, Ye X, Peng Y, Li L, Yin L, Gao X, Song B, Sun Y, Wang J, Xue W, Abrams P; Prostatic Obstruction Investigation Team (POInT). Song QX, et al. Among authors: xu z. Neurourol Urodyn. 2021 Sep;40(7):1740-1753. doi: 10.1002/nau.24737. Epub 2021 Jul 12. Neurourol Urodyn. 2021. PMID: 34252243
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Liao L, Liu Q, Cong H, Xu Z, Li E, Weng Z, Jiang H, Liu B, Huang X, Xia S, Wen W, Wu J, Shi G, Wang Y, Li P, Yu Y, Fang Z, Zheng J, Tian Y, Shang D, Li H, Huang Z, Zhou L, Xiao Y, Zhang Y, Wang J, Zhang X, Zhang P, Wang D, Zhang X, Xie K, Wang B, Ma L, Tian X, Chen L, Dong J. Liao L, et al. Among authors: xu z. Front Pharmacol. 2022 Feb 18;13:840695. doi: 10.3389/fphar.2022.840695. eCollection 2022. Front Pharmacol. 2022. PMID: 35250586 Free PMC article.
35,740 results
You have reached the last available page of results. Please see the User Guide for more information.